BioNTech logo

BioNTech

ID: 5648050

BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.

9

Funding Rounds

$1.8b

Money raised

Overview

BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company BioNTech has raised a total of $1.51b in funding over 9 rounds.

Key Insights:

  • BioNTech Grant (money), September 15, 2020: $455.6m
  • BioNTech Venture round, June 29, 2020: $250m
  • BioNTech Venture round, December 17, 2019: $60.75m
  • BioNTech Grant (money), September 4, 2019: $55m
  • BioNTech Series B round, July 2019: $325m
  • BioNTech Funding Round 2018: $91.5m
  • BioNTech Series A round, January 2017: $270m
  • BioNTech funding round, January 2018: $270m

Subsidiaries

BioNTech operates through the following subsidiaries: